What is HC Wainwright’s Estimate for ALLO Q2 Earnings?
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – Analysts at HC Wainwright increased their Q2 2025 EPS estimates for Allogene Therapeutics in a research report issued to clients and investors on Monday, June 2nd. HC Wainwright analyst R. Burns now forecasts that the company will post earnings per share of ($0.26) for the quarter, up […]
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – Analysts at HC Wainwright increased their Q2 2025 EPS estimates for Allogene Therapeutics in a research report issued to clients and investors on Monday, June 2nd. HC Wainwright analyst R. Burns now forecasts that the company will post earnings per share of ($0.26) for the quarter, up […]
